WHO ICTRP trial

Discovery and validation of genetic markers to establish effective indications…

KCT0000426 · Clinical Research Information Service (CRIS) · Recruiting

Key facts

Trial ID KCT0000426
Public title Discovery and validation of genetic markers to establish effective indications of anti-osteoporotic drugs
Scientific title Discovery and validation of genetic markers to establish effective indications of anti-osteoporotic drugs
Primary sponsor Asan Medical Center
Registry Clinical Research Information Service (CRIS)
Recruitment status Recruiting
Study type Observational Study
Countries Korea, Republic of
Conditions Diseases of the musculo-skeletal system and connective tissue
Registration date Apr 30, 2012
Target size 6604
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations